#VisualAbstract: Tumor primary site may be a prognostic factor for patients with Merkel cell carcinoma

byTeddy Guo

September 15, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Half of patients hospitalized with COVID-19 continue to have symptoms after 1 year

RelatedReports

StudyGraphics

#VisualAbstract: Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

March 24, 2023

Hidradenitis suppurativa associated with increased risk of subclinical atherosclerosis

Chronic Disease

Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

March 16, 2023

StudyGraphics

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

March 15, 2023

StudyGraphics

#VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma

March 9, 2023

Novel coronavirus identified from patients with pneumonia in Wuhan, China

In-school transmission of COVID-19 limited even during wide community spread

“No Evidence of Disease Activity” may be useful goal in multiple sclerosis

Metagenomic next-generation sequencing of cerebrospinal fluid yielded improved sensitivity and specificity for the detection of central nervous system neoplasms

Compliance-linked incentives increase infant immunizations rates in rural India

Heterologous ChAdOx1 prime-boosted vaccination schedules are non-inferior to homologous vaccination

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Tumor primary site may be a prognostic factor for patients with Merkel cell carcinoma

#VisualAbstract: Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

#VisualAbstract: Half of patients hospitalized with COVID-19 continue to have symptoms after 1 year

In-school transmission of COVID-19 limited even during wide community spread

RelatedReports

#VisualAbstract: Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

Secukinumab reduces symptoms of moderate-to-severe hidradenitis suppurativa

#StudyGraphics: Atezolizumab in combination with vemurafenib and cobimetinib improve progression-free survival in patients with BRAFV600-advanced melanoma

#VisualAbstract: Neoadjuvant–Adjuvant vs. Adjuvant-Only Pembrolizumab in Advanced Melanoma

In-school transmission of COVID-19 limited even during wide community spread

Metagenomic next-generation sequencing of cerebrospinal fluid yielded improved sensitivity and specificity for the detection of central nervous system neoplasms

Heterologous ChAdOx1 prime-boosted vaccination schedules are non-inferior to homologous vaccination

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written
medical news?

#VisualAbstract: Tumor primary site may be a prognostic factor for patients with Merkel cell carcinoma

RELATED REPORTS

#VisualAbstract: Half of patients hospitalized with COVID-19 continue to have symptoms after 1 year

In-school transmission of COVID-19 limited even during wide community spread

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

Want more physician-written medical news?

Want more physician-written
medical news?